Krishna Institute of Medical Sciences (KIMS IN): Solid Q3 Results; Expansion Plan Is on Track
309 Views12 Feb 2022 23:51
SUMMARY
- Krishna Institute of Medical Sciences (KIMS IN) shares gained ~18% since we initiated it on October 28, 2021. Investors can add to positions at the current level.
- Regional focus is still paying off and KIMS reported solid Q3 results, with revenue and PAT growing by 10% and 76%, y/y, respectively, driven by higher patient volume and occupancy.
- EBITDA margin of acquired assets has enough headroom to grow to the level of mature assets. The company is on track to add 1,650–1,800 beds in next three years.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
- Krishna Institute of Medical Sciences (KIMS IN): Improving Operations; Expansion to Drive Growth25 Jan 2023
- Krishna Institute of Medical Sciences (KIMS IN): Solid Q3 Results; Expansion Plan Is on Track12 Feb 2022
- Krishna Institute of Medical Sciences (KIMS IN): Set for Long-Term Growth Riding on Regional Focus29 Oct 2021
x